198701-03-0

Basic information

• Product Name: N-<<(4,5-dihydro-5-thioxo-1,3,4-tiadiazol-2-yl)amino>carbonyl>-O-<(1,1-dimethylethyl)dimethylsilyloxy>-L-tyrosine methyl ester
• Synonyms: N-<<(4,5-dihydro-5-thioxo-1,3,4-tiadiazol-2-yl)amino>carbonyl>-O-<(1,1-dimethylethyl)dimethylsilyloxy>-L-tyrosine methyl ester
• CAS NO: 198701-03-0
• Molecular Weight: 468.673
• Mol File: 198701-03-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N-<<(4,5-dihydro-5-thioxo-1,3,4-tiadiazol-2-yl)amino>carbonyl>-O-<(1,1-dimethylethyl)dimethylsilyloxy>-L-tyrosine methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-<<(4,5-dihydro-5-thioxo-1,3,4-tiadiazol-2-yl)amino>carbonyl>-O-<(1,1-dimethylethyl)dimethylsilyloxy>-L-tyrosine methyl ester(198701-03-0)
• EPA Substance Registry System: N-<<(4,5-dihydro-5-thioxo-1,3,4-tiadiazol-2-yl)amino>carbonyl>-O-<(1,1-dimethylethyl)dimethylsilyloxy>-L-tyrosine methyl ester(198701-03-0)

Safety Data

• Hazardous Substances Data: 198701-03-0(Hazardous Substances Data)

Upstream product

• 216974-09-3 methyl (2S)-2-amino-3-{4'-[(tert-butyldimethylsilyl)oxy]phenyl}propanoate 
• 154161-05-4 L-N-(benzyloxycarbonyl)-O-<(1,1-dimethylethyl)dimethylsilyloxy>serine methyl ester 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 98642-61-6 (2S)-2-amino-3-(tert-butyldimethylsilanyloxy)propionic acid methyl ester 
• 2349-67-9 5-amino-2,3-dihydro-1,3,4-thiadiazole-2-thione 
• 1026337-65-4 3-(tert-butyl-dimethyl-silanyloxy)-2-isocyanato-propionic acid methyl ester 

Relevant articles and documents

THIADIAZOLYL(THIO)UREAS USEFUL AS MATRIX METALLOPROTEASE INHIBITORS

The present invention provides novel thiadiazole derivatives represented by formula (I) or pharmaceutical acceptable salts thereof wherein the compounds of the present invention inhibit various enzymes from the matrix metalloproteinase family, predominant

THIADIAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES RELATED TO CONNECTIVE TISSUE DEGRADATION

The present invention provides novel thiadiazole derivatives represented by formula I: STR1 or pharmaceutical acceptable salts thereof wherein the compounds of the present invention inhibit various enzymes from the matrix metalloproteinase family, predomi